SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Andrew H who wrote (21160)5/19/1998 9:36:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Andy, Toxicity for oral retinoids (those that interact with RARs) is a MAJOR concern. Compare headaches and dry mouth caused by LGD1550 to the potential fatal effects of Roche's Vesanoid (tretinoin) used to treat APL:
pharminfo.com